Drugs

Saudi Code of Conduct for Promotional Practices of Pharmaceutical and Herbal Product in the Kingdom of Saudi Arabia

2024-02-04
Saudi Code of Conduct for Promotional Practices of Pharmaceutical and Herbal Product in the Kingdom of Saudi Arabia
Guide
Has the page content helped you?

Veterinary Products Law In Arab Gulf Cooperation Council Countries

2021-06-23
Veterinary Products Law In Arab Gulf Cooperation Council Countries
List
Has the page content helped you?

Code Procedures of Importing and Exporting

2021-05-09
Code Procedures of Importing and Exporting
Guide
Has the page content helped you?

Veterinary Incentive Project List

2021-06-10
Veterinary Incentive Project List
Has the page content helped you?

"SFDA" Withdraws and Suspends the Registration of (Omiz Plus 20mg, 40mg)

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of Omiz Plus 40/1100mg Capsule with registration number (244-277-12), and Omiz Plus 20/1100 mg Capsule with registration number (245-277-12).

SFDA added that, the medicines produced by Tabuk Pharmaceuticals.  

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings

Requirements for Clearance of Medicines, Pharmaceutical Preparations, Medical Devices , Medical Supplies and Food Supplies for the Use of Pilgrims

2025-02-20
Requirements for Clearance of Medicines, Pharmaceutical Preparations, Medical Devices , Medical Supplies and Food Supplies for the Use of Pilgrims
Procedural rule
Has the page content helped you?

Investor Guide to Obtain Scientific Office Licensing

2019-04-14
Investor Guide to Obtain Scientific Office Licensing
Guide
Has the page content helped you?

Guide for Investor to Obtain a Pharmaceutical Manufacturer License

2020-01-01
Guide for Investor to Obtain a Pharmaceutical Manufacturer License
Guide
Has the page content helped you?

Extending Validity Period for Pharmaceutical Products

2020-04-06
Extending Validity Period for Pharmaceutical Products
Guide
Has the page content helped you?
Warning Date
    2021-03-25

“SFDA” Suspends and Withdraws the Registration of (LORA S Tablet‎) and (LORINASE Tablet‎)

2021-03-25

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of the pharmaceutical product (LORA S Tablet, batch number (8-968-15)) and (LORINASE TABLETS, batch number (250-212-09) ‎).

SFDA added that (LORA S Tablet‎) is marketed by Dammam Pharma Company, whether the other product (LORINASE Tablet‎)

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings
Subscribe to Drugs